# Nalbuphine hydrochloride

NDC: 70069-661
Generic name: Nalbuphine hydrochloride
Labeler / Manufacturer: Somerset Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20240926

FDA application: ANDA216049

## Active ingredients

- NALBUPHINE HYDROCHLORIDE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70069-661"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70069-661
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d82dafac-cce7-445a-8127-2a10b6d947ca